サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1287461

メタボロミクス市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

Metabolomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 143 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.42円
メタボロミクス市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測
出版日: 2023年03月18日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

市場概要：

世界のメタボロミクス市場規模は、2022年に24億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に11.55%の成長率（CAGR）を示し、2028年までに47億米ドルに達すると予測しています。

メタボロミクスとは、細胞、生体流体、組織、生物における代謝物、または低分子の大規模な研究を指します。様々な生物学的サンプルやシステムにおいて、体系的な代謝プロファイリングやフィンガープリントを行うための分析手法です。核磁気共鳴（NMR）分光法や質量分析（MS）などのさまざまな検出技術と、ガスクロマトグラフィーなどの分離技術で構成されています。これらの技術は、メタボローム研究、毒性試験、個別化医療の開発などによく利用されています。また、健康状態の評価や、心血管疾患や神経疾患、がんなどの病気の原因や治療法についての知見を得ることができます。

がんやその他の慢性疾患の有病率の増加は、市場の成長を促進する主要な要因の1つです。さらに、製薬業界の大幅な増加や、個別化医療の需要の高まりも、市場の成長を後押ししています。メタボロミクスは、遺伝子やタンパク質の研究を促進し、医薬品の発見や開発、病気の進行管理に役立つバイオマーカーを開発することができます。さらに、メタボロミクスと機械学習（ML）の統合も、市場の成長を後押ししています。MLは、NMRやMSの技術を用いて生成されたデータの正確な解釈を支援し、複雑で反復的、時間のかかるプロセスを自動化します。また、先進的なMLソフトウェアは、大量のデータを表現するための包括的な分析および可視化機能を提供します。その他の要因として、急速な都市化やバイオテクノロジー分野における広範な研究開発活動などがあり、今後数年間は市場を牽引すると予測されます。

本レポートで回答した主な質問

  • メタボロミクスの世界市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • 主要な地域市場とは？
  • COVID-19がメタボロミクスの世界市場に与えた影響とは？
  • 製品に基づく市場の内訳は？
  • 適応症に基づく市場の内訳は？
  • アプリケーションに基づく市場の内訳は？
  • 業界のバリューチェーンにおける様々なステージは？
  • 業界における主要な促進要因と課題は何か？
  • メタボロミクスの世界市場の構造と主要プレイヤーは？
  • 業界における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者について
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 予測手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界のメタボロミクス市場

  • 市場概要
  • 市場実績
  • COVID-19のインパクト
  • 市場予測

第6章 製品別市場内訳

  • メタボロミクス機器
    • 市場動向
    • 市場予測
  • メタボロミクスバイオインフォマティクスツールおよびサービス
    • 市場動向
    • 市場予測

第7章 適応症別市場内訳

  • がん
    • 市場動向
    • 市場予測
  • 心血管疾患
    • 市場動向
    • 市場予測
  • 神経系疾患
    • 市場動向
    • 市場予測
  • 先天性代謝異常症
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 アプリケーション別市場内訳

  • バイオマーカー、創薬
    • 市場動向
    • 市場予測
  • トキシコロジー
    • 市場動向
    • 市場予測
  • ニュートリゲノミクス
    • 市場動向
    • 市場予測
  • 個別化医療
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 地域別市場内訳

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋地域
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 国別市場内訳
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の度合い
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Agilent Technologies Inc.
    • Biocrates Life Sciences AG
    • Bio-Rad Laboratories Inc.
    • Bruker Corporation
    • Danaher Corporation
    • Human Metabolome Technologies Inc.
    • Metabolon Inc.
    • Shimadzu Corporation
    • Thermo Fisher Scientific Inc.
    • Waters Corporation
図表

List of Figures

  • Figure 1: Global: Metabolomics Market: Major Drivers and Challenges
  • Figure 2: Global: Metabolomics Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Metabolomics Market: Breakup by Product (in %), 2022
  • Figure 4: Global: Metabolomics Market: Breakup by Indication (in %), 2022
  • Figure 5: Global: Metabolomics Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Metabolomics Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Metabolomics Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 8: Global: Metabolomics (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Metabolomics (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Metabolomics (Bioinformatics Tools and Services) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Metabolomics (Bioinformatics Tools and Services) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Metabolomics (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Metabolomics (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Metabolomics (Cardiovascular Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Metabolomics (Cardiovascular Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Metabolomics (Neurological Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Metabolomics (Neurological Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Metabolomics (Inborn Errors of Metabolism) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Metabolomics (Inborn Errors of Metabolism) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Metabolomics (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Metabolomics (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Metabolomics (Biomarker and Drug Discovery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Metabolomics (Biomarker and Drug Discovery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Metabolomics (Toxicology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Metabolomics (Toxicology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Metabolomics (Nutrigenomics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Metabolomics (Nutrigenomics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Metabolomics (Personalized Medicine) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Metabolomics (Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Metabolomics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Metabolomics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: North America: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: North America: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: United States: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: United States: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Canada: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Canada: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Asia Pacific: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Asia Pacific: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: China: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: China: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Japan: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Japan: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: India: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: India: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: South Korea: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: South Korea: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Australia: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Australia: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Indonesia: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Indonesia: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Others: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Others: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Europe: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Europe: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Germany: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Germany: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: France: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: France: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: United Kingdom: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: United Kingdom: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Italy: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Italy: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Spain: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Spain: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Russia: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Russia: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Others: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Others: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Latin America: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Latin America: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Brazil: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Brazil: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Mexico: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Mexico: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Others: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Others: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Middle East and Africa: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Middle East and Africa: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Global: Metabolomics Industry: SWOT Analysis
  • Figure 81: Global: Metabolomics Industry: Value Chain Analysis
  • Figure 82: Global: Metabolomics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Metabolomics Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Metabolomics Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Metabolomics Market Forecast: Breakup by Indication (in Million US$), 2023-2028
  • Table 4: Global: Metabolomics Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Metabolomics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Metabolomics Market: Competitive Structure
  • Table 7: Global: Metabolomics Market: Key Players
目次
Product Code: SR1623A162_Report

Market Overview:

The global metabolomics market size reached US$ 2.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.7 Billion by 2028, exhibiting a growth rate (CAGR) of 11.55% during 2023-2028.

Metabolomics refers to the large-scale study of metabolites, or small molecules, in cells, biofluids, tissues and organisms. It is an analytical approach for systematic metabolic profiling and fingerprinting in various biological samples and systems. It consists of various detection techniques, such as nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS), along with separation techniques, such as gas chromatography. These techniques are commonly used for metabolome studies, toxicology testing and developing personalized medicine. They also provide an assessment of health and an insight into the causes and treatment of medical ailments, such as cardiovascular and neurological diseases and cancer.

The increasing prevalence of cancer and other chronic diseases is one of the key factors driving the growth of the market. Furthermore, a significant increase in the pharmaceutical industry, along with the rising demand for personalized medicines, is also providing a boost to the market growth. Metabolomics facilitates the study of genes and proteins, along with the development of biomarkers that aid in the discovery and development of medicines and managing disease progression. Additionally, the integration of metabolomics with machine learning (ML) is also favoring the market growth. ML aids in the accurate interpretation of data generated using the NMR and MS techniques and automates complex, repetitive and time-consuming processes. Advanced ML software also offers comprehensive analysis and visualization functions for the representation of large amounts of data. Other factors, including rapid urbanization and extensive research and development (R&D) activities in the field of biotechnology, are projected to drive the market in the upcoming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global metabolomics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, indication and application.

Breakup by Product:

  • Metabolomics Instruments
  • Metabolomics Bioinformatics Tools and Services

Breakup by Indication:

  • Cancer
  • Cardiovascular Disorders
  • Neurological Disorders
  • Inborn Errors of Metabolism
  • Others

Breakup by Application:

  • Biomarker and Drug Discovery
  • Toxicology
  • Nutrigenomics
  • Personalized Medicine
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Agilent Technologies Inc., Biocrates Life Sciences AG, Bio-Rad Laboratories Inc., Bruker Corporation, Danaher Corporation, Human Metabolome Technologies Inc., Metabolon Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc., Waters Corporation, etc.

Key Questions Answered in This Report:

  • How has the global metabolomics market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global metabolomics market?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the indication?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global metabolomics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Metabolomics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Metabolomics Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Metabolomics Bioinformatics Tools and Services
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Cancer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cardiovascular Disorders
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Neurological Disorders
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Inborn Errors of Metabolism
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Biomarker and Drug Discovery
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Toxicology
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Nutrigenomics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Personalized Medicine
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Agilent Technologies Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Biocrates Life Sciences AG
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Bio-Rad Laboratories Inc.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Bruker Corporation
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
    • 13.3.5 Danaher Corporation
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 Human Metabolome Technologies Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Metabolon Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 Shimadzu Corporation
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Thermo Fisher Scientific Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Waters Corporation
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis